Sara Tartof to Risk Assessment
This is a "connection" page, showing publications Sara Tartof has written about Risk Assessment.
Connection Strength
0.155
-
Identifying patients with symptoms suspicious for COVID-19 at elevated risk of adverse events: The COVAS score. Am J Emerg Med. 2021 Aug; 46:489-494.
Score: 0.132
-
A change in vaccine efficacy and duration of protection explains recent rises in pertussis incidence in the United States. PLoS Comput Biol. 2015 Apr; 11(4):e1004138.
Score: 0.023